T. Rowe Price Associates’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-276,250
| Closed | -$307K | – | 2609 |
|
|
2018
Q2 | $307K | Sell |
276,250
-867,560
| -76% | -$964K | ﹤0.01% | 2329 |
|
|
2018
Q1 | $2.3M | Buy |
+1,143,810
| New | +$2.3M | ﹤0.01% | 1538 |
|
|
2017
Q1 | – | Sell |
-760,167
| Closed | -$3.94M | – | 2607 |
|
|
2016
Q4 | $3.94M | Sell |
760,167
-3,700
| -0.5% | -$19.2K | ﹤0.01% | 1446 |
|
|
2016
Q3 | $4.26M | Buy |
763,867
+2,667
| +0.4% | +$14.9K | ﹤0.01% | 1442 |
|
|
2016
Q2 | $4.23M | Sell |
761,200
-3,800
| -0.5% | -$21.1K | ﹤0.01% | 1419 |
|
|
2016
Q1 | $3.37M | Hold |
765,000
| – | – | ﹤0.01% | 1445 |
|
|
2015
Q4 | $4.61M | Buy |
+765,000
| New | +$4.61M | ﹤0.01% | 1428 |
|